Cerebral microembolic signals during cardiopulmonary bypass surgery - Frequency, time of occurrence, and association with patient and surgical characteristics

被引:0
作者
Braekken, SK
Russell, D
Brucher, R
Abdelnoor, M
Svennevig, JL
机构
[1] UNIV OSLO,NATL HOSP,RIKSHOSP,DEPT NEUROL,OSLO,NORWAY
[2] UNIV OSLO,NATL HOSP,RIKSHOSP,DEPT SURG,OSLO,NORWAY
关键词
cardiopulmonary bypass; embolism; ultrasonics;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose We sought to determine the number of cerebral microembolic signals (MES) and their time of occurrence during the two most frequent types of cardiopulmonary bypass (CPB) surgery: coronary artery bypass grafting (CABG) and cardiac valve replacement (VR). Furthermore, we sought to examine the association between MES, patient characteristics, and intraoperative parameters. Methods Forty-two patients were studied, 15 of whom had CABG and 27 VR. Cerebral MES were detected with the use of transcranial Doppler monitoring of the right middle cerebral artery. Results Cerebral MES were detected in all patients. The number was significantly higher during VR (median, 1048) than during CABG (median, 82) (P<.001). In VR patients, 85% of the MES were detected when the heart regained effective ejection. During CABG, the highest number was detected when the aorta was cross-clamped (18%) and on release of the side clamp (13%). The numbers of MES during the period when the aorta was cross-clamped and in association with surgical procedures were nest significantly different in the two patient groups. The total number of MES was inversely correlated to nasopharyngeal temperature (P<.01). Conclusions A significantly higher number of cerebral MES were detected during VR than during CABG. The highest number occurred in VR patients when effective heart ejection was regained and in CABG patients when the aorta was cross-clamped and on release of the side clamp. The total number of MES increased at lower nasopharyngeal temperatures. Transcranial Doppler monitoring may alert the surgical team when emboli enter the cerebral circulation during CPB surgery, thus allowing preventive measures to be taken.
引用
收藏
页码:1988 / 1992
页数:5
相关论文
共 35 条
  • [31] Prophylactic fibrinogen administration during complex congenital cardiac surgery leading to thrombosis of a patient's brachial artery and the cardiopulmonary bypass circuit: a case report
    Stanzel, R. D. P.
    Henderson, M.
    O'Bienes, S. B.
    PERFUSION-UK, 2014, 29 (04): : 369 - 372
  • [32] High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients A Randomized Controlled Trial
    Vedel, Anne G.
    Holmgaard, Frederik
    Rasmussen, Lars S.
    Langkilde, Annika
    Paulson, Olaf B.
    Lange, Theis
    Thomsen, Carsten
    Olsen, Peter Skov
    Ravn, Hanne Berg
    Nilsson, Jens C.
    CIRCULATION, 2018, 137 (17) : 1770 - +
  • [33] Changes in cerebral oxygenation during cold (28°C) and warm (34°C) cardiopulmonary bypass using different blood gas strategies (alpha-stat and pH-stat) in patients undergoing coronary artery bypass graft surgery
    Ali, MS
    Harmer, M
    Vaughan, RS
    Dunne, JA
    Latto, IP
    Haaverstad, R
    Kulatilake, ENP
    Butchart, EG
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2004, 48 (07) : 837 - 844
  • [34] A pilot study of evaluation of cerebral function by S100β protein and near-infrared spectroscopy during cold and warm cardiopulmonary bypass in infants and children undergoing open-heart surgery
    Ali, MS
    Harmer, M
    Elliott, M
    Thomas, AL
    Kirkham, F
    ANAESTHESIA, 2004, 59 (01) : 20 - 26
  • [35] Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study
    Joyeux-Faure, Marie
    Durand, Michel
    Bedague, Damien
    Protar, Daniel
    Incagnoli, Pascal
    Paris, Adeline
    Ribuot, Christophe
    Levy, Patrick
    Chavanon, Olivier
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (06) : 761 - 770